nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Diarrhoea—Ifosfamide—testicular cancer	0.000702	0.000702	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000699	0.000699	CcSEcCtD
Pamidronate—Body temperature increased—Cisplatin—testicular cancer	0.000699	0.000699	CcSEcCtD
Pamidronate—Fatigue—Etoposide—testicular cancer	0.000698	0.000698	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Pamidronate—Pain—Etoposide—testicular cancer	0.000693	0.000693	CcSEcCtD
Pamidronate—Constipation—Etoposide—testicular cancer	0.000693	0.000693	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—testicular cancer	0.000691	0.000691	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—testicular cancer	0.000686	0.000686	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—testicular cancer	0.000683	0.000683	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Pamidronate—Dizziness—Ifosfamide—testicular cancer	0.000678	0.000678	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—testicular cancer	0.000674	0.000674	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—testicular cancer	0.000669	0.000669	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—testicular cancer	0.000668	0.000668	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—testicular cancer	0.000667	0.000667	CcSEcCtD
Pamidronate—Nausea—Dactinomycin—testicular cancer	0.000665	0.000665	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—testicular cancer	0.000662	0.000662	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Pamidronate—Vomiting—Ifosfamide—testicular cancer	0.000652	0.000652	CcSEcCtD
Pamidronate—Hypersensitivity—Cisplatin—testicular cancer	0.000651	0.000651	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Pamidronate—Rash—Ifosfamide—testicular cancer	0.000647	0.000647	CcSEcCtD
Pamidronate—Dermatitis—Ifosfamide—testicular cancer	0.000646	0.000646	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—testicular cancer	0.000641	0.000641	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—testicular cancer	0.00064	0.00064	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—testicular cancer	0.00064	0.00064	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Pamidronate—Asthenia—Cisplatin—testicular cancer	0.000634	0.000634	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—testicular cancer	0.000634	0.000634	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—testicular cancer	0.00062	0.00062	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—testicular cancer	0.000618	0.000618	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—testicular cancer	0.000617	0.000617	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—testicular cancer	0.000615	0.000615	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Pamidronate—Chills—Methotrexate—testicular cancer	0.000613	0.000613	CcSEcCtD
Pamidronate—Nausea—Ifosfamide—testicular cancer	0.000609	0.000609	CcSEcCtD
Pamidronate—Diarrhoea—Cisplatin—testicular cancer	0.000605	0.000605	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—testicular cancer	0.000603	0.000603	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—testicular cancer	0.000597	0.000597	CcSEcCtD
Pamidronate—Erythema—Methotrexate—testicular cancer	0.000594	0.000594	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—testicular cancer	0.000594	0.000594	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Pamidronate—Flushing—Epirubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—testicular cancer	0.000582	0.000582	CcSEcCtD
Pamidronate—Asthenia—Etoposide—testicular cancer	0.000581	0.000581	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—testicular cancer	0.000577	0.000577	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Pamidronate—Back pain—Methotrexate—testicular cancer	0.000575	0.000575	CcSEcCtD
Pamidronate—Chills—Epirubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Pamidronate—Pruritus—Etoposide—testicular cancer	0.000573	0.000573	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—testicular cancer	0.000562	0.000562	CcSEcCtD
Pamidronate—Rash—Cisplatin—testicular cancer	0.000557	0.000557	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—testicular cancer	0.000557	0.000557	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Pamidronate—Erythema—Epirubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—testicular cancer	0.000554	0.000554	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—testicular cancer	0.000552	0.000552	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—testicular cancer	0.000549	0.000549	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Pamidronate—Tension—Epirubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—testicular cancer	0.00054	0.00054	CcSEcCtD
Pamidronate—Back pain—Epirubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—testicular cancer	0.000536	0.000536	CcSEcCtD
Pamidronate—Malaise—Methotrexate—testicular cancer	0.000536	0.000536	CcSEcCtD
Pamidronate—Dizziness—Etoposide—testicular cancer	0.000536	0.000536	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—testicular cancer	0.000532	0.000532	CcSEcCtD
Pamidronate—Chills—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Pamidronate—Nausea—Cisplatin—testicular cancer	0.000525	0.000525	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Pamidronate—Cough—Methotrexate—testicular cancer	0.000519	0.000519	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—testicular cancer	0.000515	0.000515	CcSEcCtD
Pamidronate—Vomiting—Etoposide—testicular cancer	0.000515	0.000515	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—testicular cancer	0.000514	0.000514	CcSEcCtD
Pamidronate—Agitation—Epirubicin—testicular cancer	0.000511	0.000511	CcSEcCtD
Pamidronate—Rash—Etoposide—testicular cancer	0.000511	0.000511	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—testicular cancer	0.00051	0.00051	CcSEcCtD
Pamidronate—Headache—Etoposide—testicular cancer	0.000507	0.000507	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—testicular cancer	0.000506	0.000506	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—testicular cancer	0.000506	0.000506	CcSEcCtD
Pamidronate—Tension—Doxorubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Pamidronate—Malaise—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—testicular cancer	0.0005	0.0005	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—testicular cancer	0.0005	0.0005	CcSEcCtD
Pamidronate—Syncope—Epirubicin—testicular cancer	0.000499	0.000499	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—testicular cancer	0.000489	0.000489	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Pamidronate—Cough—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—testicular cancer	0.000485	0.000485	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Pamidronate—Infection—Methotrexate—testicular cancer	0.000482	0.000482	CcSEcCtD
Pamidronate—Nausea—Etoposide—testicular cancer	0.000481	0.000481	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—testicular cancer	0.00048	0.00048	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—testicular cancer	0.000476	0.000476	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—testicular cancer	0.000472	0.000472	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—testicular cancer	0.000469	0.000469	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Pamidronate—Oedema—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—testicular cancer	0.000453	0.000453	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Pamidronate—Infection—Epirubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Pamidronate—Cough—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Pamidronate—Shock—Epirubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000442	0.000442	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—testicular cancer	0.000439	0.000439	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—testicular cancer	0.000439	0.000439	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—testicular cancer	0.000437	0.000437	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—testicular cancer	0.000436	0.000436	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—testicular cancer	0.000433	0.000433	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—testicular cancer	0.000431	0.000431	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—testicular cancer	0.000427	0.000427	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—testicular cancer	0.000422	0.000422	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000419	0.000419	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—testicular cancer	0.000418	0.000418	CcSEcCtD
Pamidronate—Infection—Doxorubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Pamidronate—Pain—Methotrexate—testicular cancer	0.000415	0.000415	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Pamidronate—Shock—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—testicular cancer	0.00041	0.00041	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000406	0.000406	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—testicular cancer	0.000405	0.000405	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—testicular cancer	0.000404	0.000404	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—testicular cancer	0.0004	0.0004	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000397	0.000397	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—testicular cancer	0.000393	0.000393	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000392	0.000392	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—testicular cancer	0.000391	0.000391	CcSEcCtD
Pamidronate—Pain—Epirubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Pamidronate—Constipation—Epirubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—testicular cancer	0.000384	0.000384	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—testicular cancer	0.000384	0.000384	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—testicular cancer	0.00038	0.00038	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—testicular cancer	0.000375	0.000375	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—testicular cancer	0.000373	0.000373	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—testicular cancer	0.00037	0.00037	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—testicular cancer	0.000365	0.000365	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000363	0.000363	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—testicular cancer	0.000362	0.000362	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Pamidronate—Pain—Doxorubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—testicular cancer	0.000357	0.000357	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—testicular cancer	0.000348	0.000348	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—testicular cancer	0.000343	0.000343	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—testicular cancer	0.000332	0.000332	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—testicular cancer	0.000326	0.000326	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—testicular cancer	0.000321	0.000321	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—testicular cancer	0.000321	0.000321	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—testicular cancer	0.000311	0.000311	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—testicular cancer	0.00031	0.00031	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Pamidronate—Rash—Methotrexate—testicular cancer	0.000306	0.000306	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—testicular cancer	0.000306	0.000306	CcSEcCtD
Pamidronate—Headache—Methotrexate—testicular cancer	0.000304	0.000304	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—testicular cancer	0.000301	0.000301	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—testicular cancer	0.0003	0.0003	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—testicular cancer	0.000297	0.000297	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Pamidronate—Nausea—Methotrexate—testicular cancer	0.000288	0.000288	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—testicular cancer	0.000287	0.000287	CcSEcCtD
Pamidronate—Rash—Epirubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Pamidronate—Headache—Epirubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Pamidronate—Nausea—Epirubicin—testicular cancer	0.00027	0.00027	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—testicular cancer	0.000267	0.000267	CcSEcCtD
Pamidronate—Rash—Doxorubicin—testicular cancer	0.000265	0.000265	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—testicular cancer	0.000265	0.000265	CcSEcCtD
Pamidronate—Headache—Doxorubicin—testicular cancer	0.000263	0.000263	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—testicular cancer	0.00025	0.00025	CcSEcCtD
